Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Author Correction: Activated β-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity.

Sumida T, Lincoln MR, Ukeje CM, Rodriguez DM, Akazawa H, Noda T, Naito AT, Komuro I, Dominguez-Villar M, Hafler DA.

Nat Immunol. 2019 Jul;20(7):943. doi: 10.1038/s41590-019-0438-6.

PMID:
31175348
2.

Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis.

Ponath G, Lincoln MR, Levine-Ritterman M, Park C, Dahlawi S, Mubarak M, Sumida T, Airas L, Zhang S, Isitan C, Nguyen TD, Raine CS, Hafler DA, Pitt D.

Nat Commun. 2018 Dec 17;9(1):5337. doi: 10.1038/s41467-018-07785-8.

3.

Activated β-catenin in Foxp3+ regulatory T cells links inflammatory environments to autoimmunity.

Sumida T, Lincoln MR, Ukeje CM, Rodriguez DM, Akazawa H, Noda T, Naito AT, Komuro I, Dominguez-Villar M, Hafler DA.

Nat Immunol. 2018 Dec;19(12):1391-1402. doi: 10.1038/s41590-018-0236-6. Epub 2018 Oct 29. Erratum in: Nat Immunol. 2019 Jul;20(7):943.

4.

Clinical Reasoning: A 34-year-old man with headache, diplopia, and hemiparesis.

Lincoln MR, Schneider R, Hohol M.

Neurology. 2016 Jan 19;86(3):e24-8. doi: 10.1212/WNL.0000000000002288. No abstract available.

PMID:
26783272
5.

Teaching neuroimages: large vagal nerve schwannoma presenting with hemorrhage and respiratory failure.

Rizek P, Lincoln MR, Wolf A, Entwistle B, Kurdi M.

Neurology. 2014 Mar 11;82(10):e89-90. doi: 10.1212/WNL.0000000000000189. No abstract available.

PMID:
24616199
6.

Robert Whytt, Benjamin Franklin, and the first probable case of multiple sclerosis.

Lincoln MR, Ebers GC.

Ann Neurol. 2012 Sep;72(3):307-11. doi: 10.1002/ana.23605. Epub 2012 Aug 22. No abstract available.

PMID:
22915153
7.

Exome sequencing identifies a novel multiple sclerosis susceptibility variant in the TYK2 gene.

Dyment DA, Cader MZ, Chao MJ, Lincoln MR, Morrison KM, Disanto G, Morahan JM, De Luca GC, Sadovnick AD, Lepage P, Montpetit A, Ebers GC, Ramagopalan SV.

Neurology. 2012 Jul 31;79(5):406-11. doi: 10.1212/WNL.0b013e3182616fc4. Epub 2012 Jun 27.

8.

HLA B*44: protective effects in MS susceptibility and MRI outcome measures.

Chao MJ, Lincoln MR, Dyment DA, Ramagopalan SV, Ebers GC.

Neurology. 2011 Aug 9;77(6):602; author reply 602-3. doi: 10.1212/WNL.0b013e318219a17e. No abstract available.

PMID:
21825276
9.

Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians.

Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, Chao MJ, Morahan J, Morrison KM, Sadovnick AD, Ebers GC.

J Neurol Sci. 2011 Jun 15;305(1-2):116-20. doi: 10.1016/j.jns.2011.02.032. Epub 2011 Mar 26.

PMID:
21440908
10.

Of mice and men: experimental autoimmune encephalitis and multiple sclerosis.

Handel AE, Lincoln MR, Ramagopalan SV.

Eur J Clin Invest. 2011 Nov;41(11):1254-8. doi: 10.1111/j.1365-2362.2011.02519.x. Epub 2011 Mar 21. Review.

PMID:
21418205
11.

Revisiting the T-cell receptor alpha/delta locus and possible associations with multiple sclerosis.

Watson CT, Para AE, Lincoln MR, Ramagopalan SV, Orton SM, Morrison KM, Handunnetthi L, Handel AE, Chao MJ, Morahan J, Sadovnick AD, Breden F, Ebers GC.

Genes Immun. 2011 Mar;12(2):59-66. doi: 10.1038/gene.2010.65. Epub 2011 Jan 27. Review.

PMID:
21270827
12.

MHC transmission: insights into gender bias in MS susceptibility.

Chao MJ, Ramagopalan SV, Herrera BM, Orton SM, Handunnetthi L, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC.

Neurology. 2011 Jan 18;76(3):242-6. doi: 10.1212/WNL.0b013e318207b060. Epub 2011 Jan 5.

13.

A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution.

Ramagopalan SV, Heger A, Berlanga AJ, Maugeri NJ, Lincoln MR, Burrell A, Handunnetthi L, Handel AE, Disanto G, Orton SM, Watson CT, Morahan JM, Giovannoni G, Ponting CP, Ebers GC, Knight JC.

Genome Res. 2010 Oct;20(10):1352-60. doi: 10.1101/gr.107920.110. Epub 2010 Aug 24.

14.

Chronic cerebrospinal venous insufficiency and multiple sclerosis.

Handel AE, Lincoln MR, Ramagopalan SV.

Ann Neurol. 2010 Aug;68(2):270. doi: 10.1002/ana.22067. No abstract available.

PMID:
20695021
15.

Parent-of-origin effects at the major histocompatibility complex in multiple sclerosis.

Chao MJ, Herrera BM, Ramagopalan SV, Deluca G, Handunetthi L, Orton SM, Lincoln MR, Sadovnick AD, Ebers GC.

Hum Mol Genet. 2010 Sep 15;19(18):3679-89. doi: 10.1093/hmg/ddq282. Epub 2010 Jul 15.

PMID:
20634196
16.

Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility.

Lincoln MR, Ramagopalan SV, Chao MJ, Herrera BM, Deluca GC, Orton SM, Dyment DA, Sadovnick AD, Ebers GC.

Proc Natl Acad Sci U S A. 2009 May 5;106(18):7542-7. doi: 10.1073/pnas.0812664106. Epub 2009 Apr 20.

17.

Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D.

Ramagopalan SV, Maugeri NJ, Handunnetthi L, Lincoln MR, Orton SM, Dyment DA, Deluca GC, Herrera BM, Chao MJ, Sadovnick AD, Ebers GC, Knight JC.

PLoS Genet. 2009 Feb;5(2):e1000369. doi: 10.1371/journal.pgen.1000369. Epub 2009 Feb 6.

18.

Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex.

Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD, Ebers GC.

Hum Mol Genet. 2009 Jan 15;18(2):261-6. doi: 10.1093/hmg/ddn353.

PMID:
19098025
19.

HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility.

Chao MJ, Barnardo MC, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Montpetit A, Sadovnick AD, Knight JC, Ebers GC.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):13069-74. doi: 10.1073/pnas.0801042105.

20.

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis.

Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, Chao MJ, Vieth R, Sadovnick AD, Ebers GC.

Am J Clin Nutr. 2008 Aug;88(2):441-7.

21.

Methylation of class II transactivator gene promoter IV is not associated with susceptibility to multiple sclerosis.

Ramagopalan SV, Dyment DA, Morrison KM, Herrera BM, Deluca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Sadovnick AD, Ebers GC.

BMC Med Genet. 2008 Jul 7;9:63. doi: 10.1186/1471-2350-9-63.

22.

Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis.

Ramagopalan SV, Deluca GC, Morrison KM, Herrera BM, Dyment DA, Lincoln MR, Orton SM, Chao MJ, Degenhardt A, Pugliatti M, Sadovnick AD, Sotgiu S, Ebers GC.

J Neurol. 2008 Aug;255(8):1215-9. doi: 10.1007/s00415-008-0878-7. Epub 2008 Jun 20.

PMID:
18563468
23.

Parent-of-origin effects in MS: observations from avuncular pairs.

Herrera BM, Ramagopalan SV, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC.

Neurology. 2008 Sep 9;71(11):799-803. doi: 10.1212/01.wnl.0000312377.50395.00. Epub 2008 May 14.

PMID:
18480463
24.

Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis.

Ramagopalan SV, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, Orton SM, Handunnetthi L, Chao MJ, Dessa Sadovnick A, Ebers GC.

J Neuroimmunol. 2008 May 30;196(1-2):170-2. doi: 10.1016/j.jneuroim.2008.03.005. Epub 2008 Apr 22.

PMID:
18433881
25.

An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locus.

DeLuca GC, Ramagopalan SV, Herrera BM, Dyment DA, Lincoln MR, Montpetit A, Pugliatti M, Barnardo MC, Risch NJ, Sadovnick AD, Chao M, Sotgiu S, Hudson TJ, Ebers GC.

Proc Natl Acad Sci U S A. 2007 Dec 26;104(52):20896-901. Epub 2007 Dec 17.

26.

Parental transmission of HLA-DRB1*15 in multiple sclerosis.

Ramagopalan SV, Herrera BM, Bell JT, Dyment DA, Deluca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC.

Hum Genet. 2008 Jan;122(6):661-3. Epub 2007 Oct 31.

PMID:
17972102
27.

Multiple sclerosis susceptibility and the X chromosome.

Herrera BM, Cader MZ, Dyment DA, Bell JT, Deluca GC, Willer CJ, Lincoln MR, Ramagopalan SV, Chao M, Orton SM, Sadovnick AD, Ebers GC.

Mult Scler. 2007 Aug;13(7):856-64.

PMID:
17881398
28.

The inheritance of resistance alleles in multiple sclerosis.

Ramagopalan SV, Morris AP, Dyment DA, Herrera BM, DeLuca GC, Lincoln MR, Orton SM, Chao MJ, Sadovnick AD, Ebers GC.

PLoS Genet. 2007 Sep;3(9):1607-13. Epub 2007 Jul 20.

29.

Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium.

Chao MJ, Barnardo MC, Lui GZ, Lincoln MR, Ramagopalan SV, Herrera BM, Dyment DA, Sadovnick AD, Ebers GC.

Hum Mol Genet. 2007 Aug 15;16(16):1951-8. Epub 2007 Jun 20.

PMID:
17584771
30.

Follow-up investigation of 12 proposed linkage regions in multiple sclerosis.

Herrera BM, Cader MZ, Dyment DA, Bell JT, Ramagopalan SV, Lincoln MR, Orton S, Chao MJ, Sadovnick AD, Ebers GC.

Genes Immun. 2006 Jul;7(5):366-71. Epub 2006 Jun 1.

PMID:
16738670
31.

PRKCA and multiple sclerosis: association in two independent populations.

Saarela J, Kallio SP, Chen D, Montpetit A, Jokiaho A, Choi E, Asselta R, Bronnikov D, Lincoln MR, Sadovnick AD, Tienari PJ, Koivisto K, Palotie A, Ebers GC, Hudson TJ, Peltonen L.

PLoS Genet. 2006 Mar;2(3):e42. Epub 2006 Mar 31.

32.

A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis.

Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, Tiislar M, Ferretti V, Tienari PJ, Sadovnick AD, Peltonen L, Ebers GC, Hudson TJ.

Nat Genet. 2005 Oct;37(10):1108-12. Epub 2005 Sep 25.

33.

Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance.

Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, Sadovnick AD, Risch N, Ebers GC.

Hum Mol Genet. 2005 Jul 15;14(14):2019-26. Epub 2005 Jun 1.

PMID:
15930013

Supplemental Content

Loading ...
Support Center